Letter: cohort study examining the association between proton pump inhibitor therapy and risk of hepatocellular carcinoma in Taiwan.

Liao, K-F; Lai, H-C; Lin, C-L; Lai, S-W

Liao, K-F; Lai, H-C; Lin, C-L; Lai, S-W.

Afiliación

Liao KF; College of Medicine, Tzu Chi University, Hualien, Taiwan.
Lai HC; Division of Hepatogastroenterology, Department of Internal Medicine, Taichung Tzu Chi General Hospital, Taichung, Taiwan.
Lin CL; College of Chinese Medicine, China Medical University, Taichung, Taiwan.
Lai SW; Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.

Aliment Pharmacol Ther ; 48(6): 689-690, 2018 09.

Article en En | MEDLINE | ID: mdl-30132939

Asunto(s)

Carcinoma Hepatocelular; Neoplasias Hepáticas; Estudios de Cohortes; Humanos; Inhibidores de la Bomba de Protones; Bombas de Protones; Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google